vs
Deckers Brands（DECK）与徕博科（LH）财务数据对比。点击上方公司名可切换其他公司
徕博科的季度营收约是Deckers Brands的1.8倍（$3.5B vs $2.0B），Deckers Brands净利率更高（24.6% vs 4.7%，领先19.9%），Deckers Brands同比增速更快（7.1% vs 5.6%），Deckers Brands自由现金流更多（$1.0B vs $490.3M），过去两年Deckers Brands的营收复合增速更高（42.8% vs 5.2%）
Deckers Brands是1973年成立的美国鞋履设计与分销企业，总部位于加利福尼亚州戈利塔，由道格·奥托与卡尔·F·洛普克共同创立。公司旗下拥有UGG、Teva、Hoka等全球知名鞋履品牌，产品覆盖休闲、户外等多个领域，销往世界多地。
徕博科（Labcorp）是全球领先的生命科学与诊断检测企业，面向医疗机构、制药企业和个人患者提供全面的临床检验服务、药物研发支持及医疗检测解决方案，依托先进科研经验与创新技术输出准确可落地的健康洞察，助力临床决策、加快新药研发，提升全球患者健康水平。
DECK vs LH — 直观对比
营收规模更大
LH
是对方的1.8倍
$2.0B
营收增速更快
DECK
高出1.5%
5.6%
净利率更高
DECK
高出19.9%
4.7%
自由现金流更多
DECK
多$530.0M
$490.3M
两年增速更快
DECK
近两年复合增速
5.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $3.5B |
| 净利润 | $481.1M | $164.7M |
| 毛利率 | 59.8% | 28.2% |
| 营业利润率 | 31.4% | 7.6% |
| 净利率 | 24.6% | 4.7% |
| 营收同比 | 7.1% | 5.6% |
| 净利润同比 | 5.3% | 14.9% |
| 每股收益（稀释后） | $3.33 | $1.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DECKLH
| Q4 25 | $2.0B | $3.5B | ||
| Q3 25 | $1.4B | $3.6B | ||
| Q2 25 | $964.5M | $3.5B | ||
| Q1 25 | $1.0B | $3.3B | ||
| Q4 24 | $1.8B | $3.3B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $825.3M | $3.2B | ||
| Q1 24 | $959.8M | $3.2B |
净利润DECKLH
| Q4 25 | $481.1M | $164.7M | ||
| Q3 25 | $268.2M | $261.1M | ||
| Q2 25 | $139.2M | $237.9M | ||
| Q1 25 | $151.4M | $212.8M | ||
| Q4 24 | $456.7M | $143.4M | ||
| Q3 24 | $242.3M | $169.3M | ||
| Q2 24 | $115.6M | $205.3M | ||
| Q1 24 | $127.5M | $228.0M |
毛利率DECKLH
| Q4 25 | 59.8% | 28.2% | ||
| Q3 25 | 56.2% | 28.8% | ||
| Q2 25 | 55.8% | 29.7% | ||
| Q1 25 | 56.7% | 28.3% | ||
| Q4 24 | 60.3% | 26.9% | ||
| Q3 24 | 55.9% | 27.6% | ||
| Q2 24 | 56.9% | 28.8% | ||
| Q1 24 | 56.2% | 28.2% |
营业利润率DECKLH
| Q4 25 | 31.4% | 7.6% | ||
| Q3 25 | 22.8% | 11.1% | ||
| Q2 25 | 17.1% | 11.2% | ||
| Q1 25 | 17.0% | 9.7% | ||
| Q4 24 | 31.0% | 6.5% | ||
| Q3 24 | 23.3% | 7.7% | ||
| Q2 24 | 16.1% | 9.2% | ||
| Q1 24 | 15.0% | 10.1% |
净利率DECKLH
| Q4 25 | 24.6% | 4.7% | ||
| Q3 25 | 18.7% | 7.3% | ||
| Q2 25 | 14.4% | 6.7% | ||
| Q1 25 | 14.8% | 6.4% | ||
| Q4 24 | 25.0% | 4.3% | ||
| Q3 24 | 18.5% | 5.2% | ||
| Q2 24 | 14.0% | 6.4% | ||
| Q1 24 | 13.3% | 7.2% |
每股收益（稀释后）DECKLH
| Q4 25 | $3.33 | $1.98 | ||
| Q3 25 | $1.82 | $3.12 | ||
| Q2 25 | $0.93 | $2.84 | ||
| Q1 25 | $-2.78 | $2.52 | ||
| Q4 24 | $3.00 | $1.72 | ||
| Q3 24 | $1.59 | $2.00 | ||
| Q2 24 | $4.52 | $2.43 | ||
| Q1 24 | $4.82 | $2.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.1B | $532.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.6B | $8.6B |
| 总资产 | $4.1B | $18.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DECKLH
| Q4 25 | $2.1B | $532.3M | ||
| Q3 25 | $1.4B | $598.1M | ||
| Q2 25 | $1.7B | $647.3M | ||
| Q1 25 | $1.9B | $369.4M | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $1.4B | $265.1M | ||
| Q1 24 | $1.5B | $99.3M |
股东权益DECKLH
| Q4 25 | $2.6B | $8.6B | ||
| Q3 25 | $2.5B | $8.7B | ||
| Q2 25 | $2.5B | $8.5B | ||
| Q1 25 | $2.5B | $8.3B | ||
| Q4 24 | $2.6B | $8.1B | ||
| Q3 24 | $2.2B | $8.2B | ||
| Q2 24 | $2.1B | $8.0B | ||
| Q1 24 | $2.1B | $8.0B |
总资产DECKLH
| Q4 25 | $4.1B | $18.4B | ||
| Q3 25 | $3.8B | $18.3B | ||
| Q2 25 | $3.8B | $18.1B | ||
| Q1 25 | $3.6B | $17.6B | ||
| Q4 24 | $4.0B | $18.4B | ||
| Q3 24 | $3.4B | $18.6B | ||
| Q2 24 | $3.3B | $16.7B | ||
| Q1 24 | $3.1B | $16.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.0B | $614.2M |
| 自由现金流经营现金流 - 资本支出 | $1.0B | $490.3M |
| 自由现金流率自由现金流/营收 | 52.1% | 13.9% |
| 资本支出强度资本支出/营收 | 1.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.17× | 3.73× |
| 过去12个月自由现金流最近4个季度 | $929.1M | $1.2B |
8季度趋势，按日历期对齐
经营现金流DECKLH
| Q4 25 | $1.0B | $614.2M | ||
| Q3 25 | $8.1M | $387.2M | ||
| Q2 25 | $36.1M | $620.6M | ||
| Q1 25 | $-73.0M | $18.5M | ||
| Q4 24 | $1.1B | $777.2M | ||
| Q3 24 | $-90.5M | $277.3M | ||
| Q2 24 | $112.7M | $561.1M | ||
| Q1 24 | $-28.7M | $-29.8M |
自由现金流DECKLH
| Q4 25 | $1.0B | $490.3M | ||
| Q3 25 | $-13.9M | $280.5M | ||
| Q2 25 | $12.2M | $542.7M | ||
| Q1 25 | $-89.4M | $-107.5M | ||
| Q4 24 | $1.1B | $665.1M | ||
| Q3 24 | $-113.4M | $161.5M | ||
| Q2 24 | $90.1M | $432.9M | ||
| Q1 24 | $-44.0M | $-163.6M |
自由现金流率DECKLH
| Q4 25 | 52.1% | 13.9% | ||
| Q3 25 | -1.0% | 7.9% | ||
| Q2 25 | 1.3% | 15.4% | ||
| Q1 25 | -8.8% | -3.2% | ||
| Q4 24 | 58.6% | 20.0% | ||
| Q3 24 | -8.6% | 4.9% | ||
| Q2 24 | 10.9% | 13.4% | ||
| Q1 24 | -4.6% | -5.2% |
资本支出强度DECKLH
| Q4 25 | 1.1% | 3.5% | ||
| Q3 25 | 1.5% | 3.0% | ||
| Q2 25 | 2.5% | 2.2% | ||
| Q1 25 | 1.6% | 3.8% | ||
| Q4 24 | 1.3% | 3.4% | ||
| Q3 24 | 1.7% | 3.5% | ||
| Q2 24 | 2.7% | 4.0% | ||
| Q1 24 | 1.6% | 4.2% |
现金转化率DECKLH
| Q4 25 | 2.17× | 3.73× | ||
| Q3 25 | 0.03× | 1.48× | ||
| Q2 25 | 0.26× | 2.61× | ||
| Q1 25 | -0.48× | 0.09× | ||
| Q4 24 | 2.40× | 5.42× | ||
| Q3 24 | -0.37× | 1.64× | ||
| Q2 24 | 0.97× | 2.73× | ||
| Q1 24 | -0.22× | -0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DECK
| UGG Brand Segment | $1.3B | 67% |
| Hoka Brand Segment | $628.9M | 32% |
| Other Brands Segment | $23.2M | 1% |
LH
| Diagnostics | $2.7B | 78% |
| Biopharma Laboratory Services | $793.0M | 23% |
